Skip to content

JOHNSON & JOHNSON

JNJ · XNYS

CIK 200406fmd_0NTEAXK4F83RXXAN3PNEWN6K3QManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2007 to Sep 27, 2026, 75 periods

Latest annual · FY2025

Millions
Total revenues
94,193
Gross profit
63,937
Net income
26,804
Free cash flow
19,698

Latest quarter · Q3 FY2026

Millions
Total revenues
25,399
Gross profit
17,302
Net income
210
Free cash flow
6,358

Daily close · JNJIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

280.33 USD

180200220240260280300Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+5.6%
Revenue, 5 yearsFY2020 to FY2025
+2.7%
Net income, 5 yearsFY2020 to FY2025
+12.7%

JOHNSON & JOHNSON (JNJ) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$94.2 billion$88.8 billion+6%10-K 2026-02-11 · proof
Gross profit$63.9 billion$61.4 billion+4.2%10-K 2026-02-11 · proof
Net income$26.8 billion$14.1 billion+90.6%10-K 2026-02-11 · proof
Cash from operating activities$24.5 billion$24.3 billion+1.1%10-K 2026-02-11 · proof
Free cash flow$19.7 billion$19.8 billion-0.7%10-K 2026-02-11 · proof
Total assets$199.2 billion$180.1 billion+10.6%10-K 2026-02-11 · proof
Total liabilities$117.7 billion$108.6 billion+8.3%10-K 2026-02-11 · proof
Cash and cash equivalents$19.7 billion$24.1 billion-18.2%10-K 2026-02-11 · proof
Total debt$47.9 billion$36.7 billion+30.8%10-K 2026-02-11 · proof
What was JOHNSON & JOHNSON (JNJ)'s revenue in fiscal 2025?
JOHNSON & JOHNSON (JNJ) reported revenue of $94.2 billion for fiscal 2025 (the year ended Dec 28, 2025), against $88.8 billion the year before (+6%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What was JOHNSON & JOHNSON (JNJ)'s gross profit in fiscal 2025?
JOHNSON & JOHNSON (JNJ) reported gross profit of $63.9 billion for fiscal 2025 (the year ended Dec 28, 2025), against $61.4 billion the year before (+4.2%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What was JOHNSON & JOHNSON (JNJ)'s net income in fiscal 2025?
JOHNSON & JOHNSON (JNJ) reported net income of $26.8 billion for fiscal 2025 (the year ended Dec 28, 2025), against $14.1 billion the year before (+90.6%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What was JOHNSON & JOHNSON (JNJ)'s cash from operating activities in fiscal 2025?
JOHNSON & JOHNSON (JNJ) reported cash from operating activities of $24.5 billion for fiscal 2025 (the year ended Dec 28, 2025), against $24.3 billion the year before (+1.1%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What was JOHNSON & JOHNSON (JNJ)'s free cash flow in fiscal 2025?
JOHNSON & JOHNSON (JNJ) reported free cash flow of $19.7 billion for fiscal 2025 (the year ended Dec 28, 2025), against $19.8 billion the year before (-0.7%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What are JOHNSON & JOHNSON (JNJ)'s total assets?
As of Dec 28, 2025, JOHNSON & JOHNSON (JNJ) reported total assets of $199.2 billion, against $180.1 billion a year earlier (+10.6%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What are JOHNSON & JOHNSON (JNJ)'s total liabilities?
As of Dec 28, 2025, JOHNSON & JOHNSON (JNJ) reported total liabilities of $117.7 billion, against $108.6 billion a year earlier (+8.3%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What are JOHNSON & JOHNSON (JNJ)'s cash and cash equivalents?
As of Dec 28, 2025, JOHNSON & JOHNSON (JNJ) reported cash and cash equivalents of $19.7 billion, against $24.1 billion a year earlier (-18.2%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
What is JOHNSON & JOHNSON (JNJ)'s total debt?
As of Dec 28, 2025, JOHNSON & JOHNSON (JNJ) reported total debt of $47.9 billion, against $36.7 billion a year earlier (+30.8%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:JNJ&period_type=annual&limit=5"

Information only, not investment advice.